Development of anti-human mesothelin-targeted chimeric antigen receptor messenger RNA–transfected peripheral blood lymphocytes for ovarian cancer therapy

CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley… - Human gene …, 2018 - liebertpub.com
CD19-targeted chimeric antigen receptor (CAR) engineered T/natural killer (NK)-cell
therapies can result in durable clinical responses in B-cell malignancies. However, CAR …
被引用次数：60 相关文章

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer …

CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley… - Human gene …, 2018 - pure.johnshopkins.edu
CD19-targeted chimeric antigen receptor (CAR) engineered T/natural killer (NK)-cell
therapies can result in durable clinical responses in B-cell malignancies. However, CAR …

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer …

CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley… - Human Gene …, 2018 - europepmc.org
CD19-targeted chimeric antigen receptor (CAR) engineered T/natural killer (NK)-cell
therapies can result in durable clinical responses in B-cell malignancies. However, CAR …

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer …

CF Hung, X Xu, L Li, Y Ma, Q Jin… - Human gene …, 2018 - pubmed.ncbi.nlm.nih.gov
CD19-targeted chimeric antigen receptor (CAR) engineered T/natural killer (NK)-cell
therapies can result in durable clinical responses in B-cell malignancies. However, CAR …

[引用][C] Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer …

CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley, C Allen… - Human Gene …, 2018 - cir.nii.ac.jp
Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger
RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy | CiNii Research …
[HTML] nih.gov

[HTML][HTML] Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian …

CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley… - Human Gene …, 2018 - ncbi.nlm.nih.gov
CD19-targeted chimeric antigen receptor (CAR) engineered T/natural killer (NK)-cell
therapies can result in durable clinical responses in B-cell malignancies. However, CAR …

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer …

CF Hung, X Xu, L Li, Y Ma, Q Jin, A Viley… - Human Gene …, 2018 - europepmc.org
CD19-targeted chimeric antigen receptor (CAR) engineered T/natural killer (NK)-cell
therapies can result in durable clinical responses in B-cell malignancies. However, CAR …